Andarine
Andarine (S-4) is the cutting SARM known for dryness, vascularity, and a distinct vision side effect. It is used for a harder look and strength retention in a calorie deficit rather than mass gain.
Its signature downside is yellow-tinted vision or poor night adaptation, especially at higher doses. That side effect often decides whether the compound is practical.
Andarine is chosen when the goal is cosmetic tightening during a cut without using a dry oral steroid. It can help users look harder while preserving performance in a calorie deficit.
Andarine fits users who want something more visible than Ostarine but less systemically aggressive than RAD or S-23. The tradeoff is that the eye side effect is not subtle when it shows up.
Administration: Oral compound. Most users take it with a fixed daily schedule rather than chasing short-term effect swings.
Cycle context: Treat this like a suppressive research drug, not a harmless shortcut. Labs before and after matter even when the compound is marketed as mild.
Stop or reduce if: blood pressure climbs, sleep degrades, libido crashes, or labs move sharply in the wrong direction.
Because the half-life is short, users often notice the feel and visual effects fairly quickly and split dosing across the day. That short kinetic profile also means the compound can feel uneven if dosing is inconsistent.
The expected result is not large mass gain. It is strength retention, vascularity, dryness, and a more finished look when body fat is already moving down.
Andarine, or S-4, is the cutting SARM known for a dry look and a strange visual side effect. It can improve hardness, vascularity, and strength retention in a deficit, but its yellow-tint and night-vision issues make it one of the most self-limiting SARMs in real use.
The compound’s niche is visual. It does not compete with LGD-4033 for mass or RAD-140 for aggressive strength. It is more like a SARM attempt at the Winstrol idea: harder, drier, sharper, and better suited to a cut than a bulk.
The eye effect is the defining property. Users report yellow-tinted vision, slow dark adaptation, and poor night vision, especially at higher doses or with continuous exposure. For some, it is mild and reversible. For others, it makes the compound not worth using.
The main mistake is pushing through vision changes as if they are just a nuisance. If night driving or normal function is affected, the compound has become impractical.
Another mistake is expecting Andarine to create definition at high body fat. Like Winstrol or Masteron, it sharpens what is already there.
Compared with Ostarine, Andarine is more cosmetic and cutting-focused but less comfortable.
Compared with Winstrol, Andarine aims at a similar dry look with a different side-effect set. Winstrol is harder on joints and lipids; Andarine’s signature issue is vision.
Compared with RAD-140, Andarine is less strength-forward and less aggressive overall.
Natural suppression with reduced fertility and testicular output
Visual tinting, trouble adjusting to darkness, and dose-related eye disturbances
CBC / hematocrit
blood pressure
lipid panel
Uncontrolled hypertension or untreated cardiovascular disease
Pre-existing severe infertility concerns unless that risk is accepted and managed